Arcutis Biotherapeutics had a revenue of 81.50M in the quarter ending Jun 30, 2025, with 23.78%. This bring the company's revenue in the last twelve months to 263.46M, Decreased 23.80%. In the fiscal year ending Dec 31, 2024, Arcutis Biotherapeutics had annual revenue of 196.54M with 229.74% growth.